Cerevel Therapeutics Holdings Overview

Cerevel Therapeutics Holdings Gross Profit

Gross Profit analysis for CERE.

Quarterly Gross Profit

$-1541000.00

↑ 16.65% YoY

As of Mar 31, 2024

Annual Gross Profit (TTM)

$2.40M

↓ 161.78% YoY

Trailing 12 months ending Mar 31, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin